Scleroderma in children: Emerging management issues. The rarity of scleroderma in children and the self-limiting nature of the disease together make randomized controlled trials very difficult. Therefore, most data on therapeutic modalities for this condition have to be extrapolated from studies conducted on adults.Saumya Panda. (PubMed) Indian J Dermatol Venereol Leprol. 2010 Jul-Aug;76(4):348-56. (Also see: Juvenile Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Scleroderma in children: Emerging management issues
No replies to this topic